Pulse Biosciences (PLSE)

• Market cap: $1.08B
• 1 day: -0.17%
• 5 days: -3.19%
• 1 month: -8.47%
• 3 months: -0.90%
• 6 months: 7.51%
• Year to date: -1.01%
• 1 year: 112.17%
• 5 years: 24.98%
• 10 years: 322.30%
• Sector: Healthcare
• Industry: Surgical & Medical Instruments & Apparatus

About: Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.

Employees: 56

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

567% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 3

120% more call options, than puts

Call options by funds: $3.34M | Put options by funds: $1.52M

81% more capital invested

Capital invested by funds: $54.6M [Q2] → $98.6M (+$44M) [Q3]

26% more funds holding

Funds holding: 57 [Q2] → 72 (+15) [Q3]

22% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 18

0.34% more ownership

Funds ownership: 8.83% [Q2] → 9.18% (+0.34%) [Q3]